Kinga Zapert

ASCO25 Oncologists’ Perspective: Not a “lame-duck” conference! Immediate practice-changing developments recognized, along with a promise of major transformations in the longer term

The American Society of Clinical Oncology's 2025 Annual Meeting defied industry expectations, delivering meaningful clinical advances that have the potential to change oncology practice. Despite some industry analysts describing #ASCO25 as lacking in

Promotional Tracking

2024 Lung Cancer Developments

ZOOMRX Global Oncology Panel’s Perspectives The last couple of months have brought some high-profile developments in non-small cell lung cancer (NSCLC) including critical data released at the World Conference on Lung Cancer

Promotional Tracking

ASCO 2024: What the Post-conference Survey Reveals

This year marked the 60th Annual ASCO Conference—and as befits an august institution, it was noteworthy. Over 40,000 oncologists, industry professionals and patient advocacy activists gathered at Chicago’s McCormick Place

News

ASCO 2023 : From the Oncologists’ Perspective

ASCO Annual Meeting 2023 led with the theme of Improving Patients' Lives Through Collaboration, Research, and Innovation, creating positive experiences among those who attended and generating excitement about practice-changing data. The ZoomRx survey

Oncology

Oncologists share exclusive insights on the developments in breast cancer therapies in the past year

Breast Cancer Awareness Month (BCAM) is a time to celebrate the strength of breast cancer survivors and to champion all of those who are fighting to eradicate this group of diseases. At ZoomRx,

Oncology

Cancer Moonshot: Oncologists express optimism about cutting cancer-related deaths

Oncologists on the ZoomRx panel express their thoughts on the Cancer Moonshot initiative.

Oncology

2022 ASCO Annual Meeting: Major Scientific Progress Moves the Field of Oncology Beyond COVID

A strong line up of potentially practice-changing presentations generated a great deal of excitement among attendees at ASCO#2022 – both those in person at the McCormick Convention Center and those attending virtually. Based

Oncology

Oncologists' Perspectives on Recent Developments in Advanced Breast Cancer: Promising Progress with Curative Intent Just Out of Reach

Recent developments across three subtypes of advanced breast cancer – HER2+, TNBC, and HR+/HER2- have generated enthusiasm among oncologists in the United States. While oncologists are stopping short of calling advanced breast cancer

Conferences

New Data in Early Settings and the Continued Development of Immunotherapies Captured Attention during ASCO's 2021 Annual Meeting.

Among clinical topics, new data in early settings and continued development of immunotherapies stood out to oncologists as areas that can change their practice in the immediate future.

Conferences

ESMO 2020 delivered data representing major progress in oncology, as oncologists grow more accustomed to the virtual format

Oncologists are growing accustomed to attending the field’s major meetings virtually, with AACR, ASCO, and now ESMO 2020 having gone fully digital. While the virtual format has undoubtedly impacted attendees’ experiences and

Oncology

Understanding the role of PSA In Prostate Cancer Oncologist-Patient Dialogue

The prostate-specific antigen (PSA) score has become a critical post-diagnosis tool for oncologists as they discuss prostate cancer disease state with their patients along with their families and caregivers. Oncologist-patient relationships are based

Conferences

ASCO20 Delivered Practice-Changing Data in a Highly Accessible, Virtual Format; Despite Reduced Levels of Engagement among Oncologists

Despite the disruption and transition to a completely virtual format, 2020 was not an off-year for ASCO. Nearly all oncologists who attended this year’s ASCO Annual Meeting felt that it represented at

Conferences

ASCO20 Moves From McCormick Place: Oncologists Prepare for a Virtual Meeting

With the ASCO 2020 Annual Meeting just days away, oncologists are nearly universally planning to “attend” this year’s virtual meeting. However, their participation in the meeting will be less in real-time and

Covid-19

Telemedicine and Breast Cancer Patient Care during the COVID-19 Pandemic: Oncologists' Perspective

COVID-19 has served as a catalyst for the rapid uptake of telemedicine across a range of therapeutic categories. Initially, physicians adopted telemedicine, despite uncertainty surrounding reimbursement, in order to ensure the safety of

Conferences

ASH 2019: Hem-oncs share their perspective on the latest in MM and CLL treatment among other key topics

Nearly 30,000 hematology specialists gathered for this year’s 2019 American Society of Hematology (ASH) annual meeting held Dec 7-10 in Orlando, Florida. This year’s conference delivered on its promise to

Conferences

Getting ready for ASH 2019: Perspective from the ZoomRx hem-onc panel

The ASH 2019 Annual Meeting kicks-off this Saturday (12/7) in Orlando. Our survey of 51 practicing hematologists-oncologists indicated a great deal of excitement and anticipation, as they prepare for the meeting. In

Conferences

JAKs continue to capture attention, new MOAs stir excitement at ACR 2019

This year’s annual meeting held November 8-13 did not disappoint according to a ZoomRx survey with 35 rheumatologists who attended the conference.

Conferences

Oncologists on ESMO 2019 and the Potential Impact of Key PARP Inhibitor Data

Following this year’s ESMO annual meeting we asked a group of oncologists practicing in the US to weigh in on Europe’s biggest oncology conference. Oncologists expressed general excitement about the meeting,

Conferences

Oncologists reflect on ASCO 2019

The data shared at this year's ASCO Annual Meeting moved the field of clinical oncology forward. Our survey with over 60 oncologists who attended the conference shows that ASCO 2019 did not disappoint.

Conferences

Practicing Oncologists Weigh In on ASCO's 2019 Annual Meeting

With ASCO just days away, oncologists are divided in their outlook for this year's meeting. In our survey of 54 practicing oncologists who plan on attending the conference, half (52%) reported they expect

Conferences

Breakthrough Treatments and Pharma's Pricing Dilemma - Perspective from AAN 2019

The recent 2019 AAN conference (May 4-10, Philadelphia) brought promising new data in rare diseases, generating a great deal of excitement and anticipation for new therapies.